Michelle Glass Selected Research

cumyl-PINACA

2/2019

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle Glass Research Topics

Disease

8	Hypothermia 01/2023 - 08/2015
6	Inflammation (Inflammations) 01/2022 - 01/2007
4	Pain (Aches) 01/2022 - 01/2009
3	Bradycardia 01/2023 - 09/2015
3	Huntington Disease (Huntington's Disease) 09/2014 - 04/2006
2	Stroke (Strokes) 01/2022 - 01/2007
2	Pica (Geophagia) 11/2020 - 02/2019
2	Vomiting 01/2019 - 06/2010
2	Central Nervous System Diseases (CNS Diseases) 01/2017 - 08/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2010 - 06/2008
1	Neuralgia (Stump Neuralgia) 01/2024
1	Amphetamine-Related Disorders (Addiction, Amphetamine) 05/2022
1	Schizophrenia (Dementia Praecox) 05/2022
1	Mental Disorders (Mental Disorder) 05/2022
1	Ischemia 01/2022
1	Epilepsy (Aura) 01/2022
1	Cocaine-Related Disorders (Cocaine Addiction) 10/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Catalepsy 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Nausea 01/2019
1	Anorexia Nervosa 01/2019
1	Chronic Pain 01/2019
1	Tourette Syndrome (Tourette's Syndrome) 01/2019
1	Multiple Sclerosis 01/2019
1	Autistic Disorder (Autism) 01/2018
1	Parkinson Disease (Parkinson's Disease) 12/2014
1	Melanoma (Melanoma, Malignant) 12/2012
1	Neoplasms (Cancer) 12/2012
1	Reperfusion Injury 04/2012
1	Premature Obstetric Labor (Premature Labor) 02/2008
1	Rupture 02/2008
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2007
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2007
1	Brain Injuries (Brain Injury) 01/2007
1	Spontaneous Abortion (Miscarriage) 10/2004

Drug/Important Bio-Agent (IBA)

13	CannabinoidsIBA 01/2024 - 10/2004
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2024 - 04/2006
5	CB2 Cannabinoid ReceptorIBA 01/2022 - 01/2007
5	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 04/2006
5	EndocannabinoidsIBA 01/2020 - 01/2007
2	anandamide (arachidonylethanolamide)IBA 01/2022 - 10/2004
1	Dronabinol (THC)FDA LinkGeneric 01/2023
1	methyl 2- (1- (4- fluorobenzyl)- 1H- indazole- 3- carboxamido)- 3- methylbutanoateIBA 01/2023
1	Amphetamine (Amfetamine)FDA LinkGeneric 05/2022
1	CannabidiolIBA 05/2022
1	CarbonIBA 01/2022
1	N-acylethanolaminesIBA 01/2022
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2022
1	LipidsIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2021
1	5F-CUMYL-PICAIBA 11/2020
1	EG-018IBA 01/2020
1	RimonabantIBA 01/2020
1	cumyl-PINACAIBA 02/2019
1	5F-CUMYL-P7AICAIBA 02/2019
1	methyl (1- (5- fluoropentyl)- 1H- indazole- 3- carbonyl)valinateIBA 01/2016
1	N- (1- amino- 3- methyl- 1- oxobutan- 2- yl)- 1- pentyl- 1H- indazole- 3- carboxamideIBA 09/2015
1	AB-FUBINACAIBA 09/2015
1	1-pentyl-3-(1-naphthoyl)indoleIBA 08/2015
1	Ion Channels (Ion Channel)IBA 12/2014
1	HU-910IBA 04/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2009
1	Biomarkers (Surrogate Marker)IBA 06/2008
1	Mutant Proteins (Protein, Mutant)IBA 06/2008
1	ProstaglandinsIBA 02/2008
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2006
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 10/2004
1	EnzymesIBA 10/2004

Therapy/Procedure

3	Therapeutics 12/2012 - 04/2006
2	Analgesia 06/2010 - 01/2009
1	Drug Therapy (Chemotherapy) 01/2019
1	Induced Hypothermia 09/2015
1	Immunotherapy 12/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2012